Intragraft mechanisms associated with the immunosuppressive versus the tolerogenic effect of CD3 antibodies in a mouse model of islet allografts.

[1]  H. Volk,et al.  Induction of Allograft Tolerance by Monoclonal CD3 Antibodies: A Matter of Timing , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  Graham M Lord,et al.  Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. , 2010, The Journal of clinical investigation.

[3]  C. Larsen,et al.  Translating costimulation blockade to the clinic: lessons learned from three pathways , 2009, Immunological reviews.

[4]  R. Abdi,et al.  Phenotypic and Functional Differences Between Wild-Type and CCR2−/− Dendritic Cells: Implications for Islet Transplantation , 2008, Transplantation.

[5]  J. Bluestone,et al.  CD3-specific antibodies: a portal to the treatment of autoimmunity , 2007, Nature Reviews Immunology.

[6]  H. Volk,et al.  Identification of Gene Markers for the Prediction of Allograft Rejection or Permanent Acceptance , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7]  H. Auchincloss,et al.  The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection. , 2002, Diabetes.